Fizazi A, Serrand C, Evrard A, Bergeret B, Stoebner P-E, Marque M. High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors. Acta Derm Venereol [Internet]. 2024 Nov. 7 [cited 2026 Apr. 29];104:adv40913. Available from: https://medicaljournalssweden.se/actadv/article/view/40913